Population biobank as a basis for determining spatial variation of clinically relevant pharmacogenetic biomarkers of cardiovascular diseases

Population biobank as a basis for determining spatial variation of clinically relevant pharmacogenetic biomarkers of cardiovascular diseases

The introduction of pharmacogenetic tests among the Russian population faces a fundamental limitation — pronounced genetic differences between populations. The genetic geography of pharmacogenetic markers of deoxyribonucleic acid (DNA) helps to remove these limitations.Aim. To reveal the spatial va...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. Yu. Pylev, A. T. Agdzhoyan, I. O. Gorin, V. S. Petrushenko, E. A. Pocheshkhova, K. B. Mirzaev, E. V. Balanovskaya
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2022-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	population biobank dna markers pharmacogenetics cardiovascular diseases population genetics genetic geography
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3430
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genogeographic technologies of a population biobank as a tool for assessing selection effects (using the example of pharmacogenetic biomarkers of cardiovascular diseases)
by: E. V. Balanovskaya, et al.
Published: (2023-12-01)

Population-based biobank for analyzing the frequencies of clinically relevant DNA markers in the Russian population: bioinformatic aspects
by: I. O. Gorin, et al.
Published: (2020-12-01)

Development of a biobank in the structure of scientific and diagnostic and treatment institutions and prospects for interregional integration
by: R. S. Kalinin, et al.
Published: (2022-12-01)

Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive review
by: Rania Magadmi
Published: (2025-12-01)

Impact of pharmacogenetics on aspirin resistance: a systematic review
by: Gustavo Figueiredo da Silva, et al.
Published: (2023-01-01)

Validation of genetic risk scores for type 2 diabetes on a Russian population sample from the biobank of the National Medical Research Center for Therapy and Preventive Medicine
by: A. V. Kiseleva, et al.
Published: (2023-12-01)

Pharmacogenetic Study of Anti‐TB Drugs in the Native Ancestry Peruvian Population
by: Luis Jaramillo‐Valverde, et al.
Published: (2025-06-01)

Role of biobanking in the development of personalized medicine in Russia and the world
by: M. S. Pokrovskaya, et al.
Published: (2025-01-01)

Allele and genotype frequencies of variants in P450 cytochromes, transports, and DNA repair enzymes in the Dominican Republic population
by: Elizabeth Pérez-Duval, et al.
Published: (2025-03-01)

Lessons from national biobank projects utilizing whole-genome sequencing for population-scale genomics
by: Hyeji Lee, et al.
Published: (2025-03-01)

Impact of Pharmacogenetics on High-Dose Methotrexate Toxicity in Pediatric Oncology
by: Luciana Maria Marangoni-Iglecias, et al.
Published: (2025-04-01)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015-09-01)

Pharmacogenetics of antiretroviral drugs
by: Dragović Gordana, et al.
Published: (2012-01-01)

Optimizing UK biobank cloud-based research analysis platform to fine-map coronary artery disease loci in whole genome sequencing data
by: Letitia M.F. Sng, et al.
Published: (2025-03-01)

Contributions of common and rare genetic variation to different measures of mood and anxiety disorder in the UK Biobank
by: Ioanna K. Katzourou, et al.
Published: (2025-05-01)

Pharmacogenetic testing: current state of the issue
by: O. V. Kraidashenko, et al.
Published: (2024-11-01)

New bearings in pharmacotherapeutic strategies: Pharmacogenetics and gene therapy
by: Grbović Leposava, et al.
Published: (2007-01-01)

Returning of individual genetic findings to biobank participants: a mixed methods study results in Lithuania
by: Jūratė Lekstutienė, et al.
Published: (2025-07-01)

Population Research, Its Relevance and Topicality
by: Jelonek Adam
Published: (2008-01-01)

biobank.cy: the Biobank of Cyprus past, present and future
by: Eleni M. Loizidou, et al.
Published: (2024-11-01)

Management of biobanking for medical genetics research
by: V. Yu. Tabakov
Published: (2022-01-01)

Genotyping by Amplicon Sequencing (GBAS) With Newly Developed SSR and EPIC Markers Reveals Structure in Populations of the Green Toad (Bufotes viridis) Across Rural and Urban Environments
by: Vincent Kendlbacher, et al.
Published: (2025-07-01)

Pharmacogenetics or predictive genetics? APOE testing blurs the lines
by: Stefania Zampatti, et al.
Published: (2025-07-01)

Comparative pharmacogenetic study of disulfiram or cyanamide efficacy for alcohol dependence: the key role of dopamine neurotransmission gene polymorphisms
by: A. O. Kibitov, et al.
Published: (2023-07-01)

Role of biobanks in the study of population immunity
by: O. S. Konshina, et al.
Published: (2018-07-01)

THE COMPARATIVE EFFICACY OF PERSONALIZING THERAPY WITH ANTICONVULSANTS AND ANTIPSYCHOTICS ON THE BASIS OF PHARMACOGENETIC TESTING
by: T. V. Dokukina, et al.
Published: (2016-08-01)

Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)
by: N. A. Shnayder, et al.
Published: (2024-07-01)

Shelf life of whole blood samples in a biobank and the yield of deoxyribonucleic acid during genetic testing
by: O. P. Skirko, et al.
Published: (2020-12-01)

GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
by: Laura R. Claus, et al.
Published: (2024-01-01)

Pharmacogenetics of cerebrovascular metabolism modulators in dementia due to Alzheimer’s disease
by: Fabricio Ferreira de Oliveira
Published: (2015-03-01)

Genome‐Wide Development and Characterization of Microsatellite Markers in the Great Web‐Spinning Sawfly Acantholyda posticalis
by: Mengfei Liu, et al.
Published: (2024-11-01)

From idea to implementation: the development of biobanking in Russia. The Cardiovascular Therapy and Prevention journal’s top contributing institutions: National Association of Biobanks and Biobanking Specialists (NASBIO)
by: A. N. Meshkov, et al.
Published: (2023-12-01)

Biosample collection in a biobank to solve problems of personalized medicine
by: O. V. Kopylova, et al.
Published: (2025-01-01)

Training in biobanking in the context of modern medical education
by: T. S. Sokolova, et al.
Published: (2022-12-01)

The pharmacogenetics antiepileptic drugs
by: N. A. Shnayder, et al.
Published: (2008-12-01)

ISSR fingerprinting of genetic diversity within and among Orobanche cumana wallr. populations from different countries
by: Ina Bivol
Published: (2024-10-01)

Editorial: Challenges and prospects for conservation genetics at XXI century
by: Patricia Amavet, et al.
Published: (2025-02-01)

Prevalence of clinician-ordered genetic testing in rural and urban United States counties: An analysis of the 2022 Health Information National Trends Survey
by: Anne C. Madeo, et al.
Published: (2025-09-01)

Genetic Diversity and Population Structure of Fusarium oxysporum f. sp. cepae, the Causal Agent of Fusarium Basal Plate Rot on Onion using RAPD Markers
by: Harun Bayraktar
Published: (2010-09-01)

Clinically relevant genetic variants of drug-metabolizing enzyme and transporter genes detected in Thai children and adolescents with autism spectrum disorder
by: Medhasi S, et al.
Published: (2016-04-01)